CSIMarket Company Name, Ticker, Competitors, else..
 
Cognition Therapeutics inc   (NASDAQ: CGTX)
 

Cognition Therapeutics Inc's Suppliers Performance

CGTX's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
CGTX Costs vs Sales of Suppliers Growth

• More on CGTX Suppliers






Cognition Therapeutics Inc's Comment on Supply Chain


The company utilizes a contract manufacturer for the supply of the zervimesine drug substance and a single third-party contract manufacturer for clinical trial supplies of zervimesine. Prior to potential approval, the company intends to establish commercial supply agreements with these manufacturers. The current drug substance manufacturer supports all requirements for planned clinical studies and commercial supplies. Zervimesine drug product is produced using conventional pharmaceutical processing methods with commercially available excipients and packaging materials. The manufacturing procedures and equipment are standard and transferable to various facilities. The company plans to transition from the current drug product manufacturer to a larger third-party manufacturer for late-stage clinical and commercial supply.

Cognition Therapeutics Inc's Comment on Supply Chain


The company utilizes a contract manufacturer for the supply of the zervimesine drug substance and a single third-party contract manufacturer for clinical trial supplies of zervimesine. Prior to potential approval, the company intends to establish commercial supply agreements with these manufacturers. The current drug substance manufacturer supports all requirements for planned clinical studies and commercial supplies. Zervimesine drug product is produced using conventional pharmaceutical processing methods with commercially available excipients and packaging materials. The manufacturing procedures and equipment are standard and transferable to various facilities. The company plans to transition from the current drug product manufacturer to a larger third-party manufacturer for late-stage clinical and commercial supply.







CGTX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Cognition Therapeutics inc 86.09 0.00 -27.99 14
SUBTOTAL 0.00 0.00 0.00 -


Sources: Cognition Therapeutics inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Cognition Therapeutics inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.